06.03.2013 Views

IMS Company Profiles - Report Buyer

IMS Company Profiles - Report Buyer

IMS Company Profiles - Report Buyer

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>IMS</strong> COM PANY PRO FILES NOVARTIS<br />

Financial Data<br />

Key Figures<br />

Share Data: Shares are quoted on the Swiss stock ex change in Zu rich, and the New York Stock Ex -<br />

change. Shares are also traded on the SEAQ In ter na tional, Lon don.<br />

Key Fig ures: Key Fig ures for Years end ing De cem ber 31:<br />

Unit: $ mil lions, ex cept EPS in $<br />

2008 2007 2006 2005 2004<br />

Net Sales 41,459 39,800 37,020 32,212 28,247<br />

R&D 7,217 6,430 5,321 4,846 4,077<br />

Pre-Tax Profit 9,499 7,487 7,994 7,265 6,693*<br />

Net Profit 8,233 11,968 7,202 6,141 5,380*<br />

EPS ($) 3.59 5.13 3.04 2.63 2.27*<br />

Total Assets 78,299 75,452 68,008 57,732 52,488<br />

Shareholder’s Equity 50,437 49,396 41,294 33,164 31,315<br />

Source: Novartis Jan u ary 2009/Novartis An nual Re ports<br />

*Note: Re stated (new IFRS rules)<br />

© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 108

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!